The chronic loss of PERK expression over the four-week period between when defects in beta cell development are first seen during the fetal stage and the onset of overt diabetes three weeks after birth confounds resolving these questions and determining the molecular basis of the defects in Perk-deficient mice. The gene discussed is EIF2AK3; the disease is diabetes mellitus.